MARKET

ENSCW

ENSCW

Ensysce Biosciences Inc
OTCPK
0.015
+0.005
+50.00%
Closed 13:44 12/05 EST
OPEN
0.015
PREV CLOSE
0.010
HIGH
0.015
LOW
0.015
VOLUME
5.00K
TURNOVER
75
52 WEEK HIGH
0.030
52 WEEK LOW
0.0050
MARKET CAP
--
P/E (TTM)
-0.0024
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENSCW last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at ENSCW last week (1117-1121)?
Weekly Report · 11/24 10:39
Weekly Report: what happened at ENSCW last week (1110-1114)?
Weekly Report · 11/17 10:40
Weekly Report: what happened at ENSCW last week (1103-1107)?
Weekly Report · 11/10 10:37
Weekly Report: what happened at ENSCW last week (1027-1031)?
Weekly Report · 11/03 10:37
Weekly Report: what happened at ENSCW last week (1020-1024)?
Weekly Report · 10/27 10:42
Weekly Report: what happened at ENSCW last week (1013-1017)?
Weekly Report · 10/20 10:37
Weekly Report: what happened at ENSCW last week (1006-1010)?
Weekly Report · 10/13 10:40
More
About ENSCW
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. The MPAR platform, when combined with its TAAP prodrugs, is designed to seek to prevent abuse of prescription drugs but also to reduce overdose occurrences. Additionally, nafamostat di-mesylate (nafamostat), which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

Webull offers Ensysce Biosciences Inc stock information, including OTCPK: ENSCW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENSCW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENSCW stock methods without spending real money on the virtual paper trading platform.